Nucleome Therapeutics raised €38M in a Series A round in Oct 2022. The company is based in Oxford, UK. Investors in the round: British PatientCapital, Johnson & Johnson Innovation – JJDC, M Ventures and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
